Partner With Us


We continue to evaluate new in-licensing and acquisition opportunities to further expand our pipeline of novel, differentiated and disruptive programs.

We focus on drug candidates that:

  • Satisfy an unmet human need or provide a newer, improved alternative to existing therapies
  • Have demonstrated positive results in animal disease models or human studies
  • Are capable of or have been patent protected
  • Possess significant sales potential in major global markets

If you have a technology that you believe may be of interest to us, please emailĀ